BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

GLYCOMIMETICS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

GLYCOMIMETICS, INC.

via TARPLIN, DOWNS & YOUNG, LLC

4th Quarter (Oct 1 - Dec 31) · 2010Posted Jan 19, 2011Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: GLYCOMIMETICS, INC.
Description: GlycoMimetics, Inc. specializes in small molecule therapeutics
Location: Maryland · United States of America

Registrant

Firm: TARPLIN, DOWNS & YOUNG, LLC
Description: Health care policy and regulatory and legislative consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
no specific bills Sickle Cell Anemia education and research advocacy
LobbyistsISAAC A FORDJOUR
TargetedHOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.